: Detailed breakdowns of biologic therapies and small molecule inhibitors for inflammatory bowel disease (IBD).
: The edition includes over 1,100 full-color illustrations , clinically practicable algorithms, and more than 20 procedural videos . Book Specifications Publisher Elsevier Publication Date December 10, 2025 Page Count 2,560 pages Format 2-Volume Set (Hardcover) or eBook ISBN-13 978-0443116575
12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is available for purchase online or through a medical bookstore. Healthcare professionals can order the textbook or online subscription by visiting the publisher's website or contacting a medical bookstore.
5/5 stars
: New coverage of AI applications in endoscopy to enhance the detection of gastrointestinal cancers. COVID-19 Impact
: Key diagnostic criteria, drug dosages, and disease staging systems are organized into concise, high-density reference boxes.
Together, they have consolidated insights from hundreds of international contributors to shift the textbook’s focus toward precision medicine and advanced technological interventions. What’s New in the 12th Edition? 1. Integration of Artificial Intelligence (AI)
, scheduled for release in , is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.
If you are looking to utilize this text for specific purposes,g., IBD therapies or MASH guidelines) Compare its features with Let me know how you would like to proceed.
: Fully integrates the new nomenclature for Metabolic Dysfunction-Associated Steatotic Liver Disease ( MASLD ), replacing the historical term NAFLD.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations
: Detailed breakdowns of biologic therapies and small molecule inhibitors for inflammatory bowel disease (IBD).
: The edition includes over 1,100 full-color illustrations , clinically practicable algorithms, and more than 20 procedural videos . Book Specifications Publisher Elsevier Publication Date December 10, 2025 Page Count 2,560 pages Format 2-Volume Set (Hardcover) or eBook ISBN-13 978-0443116575
12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is available for purchase online or through a medical bookstore. Healthcare professionals can order the textbook or online subscription by visiting the publisher's website or contacting a medical bookstore.
5/5 stars
: New coverage of AI applications in endoscopy to enhance the detection of gastrointestinal cancers. COVID-19 Impact
: Key diagnostic criteria, drug dosages, and disease staging systems are organized into concise, high-density reference boxes.
Together, they have consolidated insights from hundreds of international contributors to shift the textbook’s focus toward precision medicine and advanced technological interventions. What’s New in the 12th Edition? 1. Integration of Artificial Intelligence (AI)
, scheduled for release in , is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.
If you are looking to utilize this text for specific purposes,g., IBD therapies or MASH guidelines) Compare its features with Let me know how you would like to proceed.
: Fully integrates the new nomenclature for Metabolic Dysfunction-Associated Steatotic Liver Disease ( MASLD ), replacing the historical term NAFLD.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations
